<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02672553</url>
  </required_header>
  <id_info>
    <org_study_id>2011-12</org_study_id>
    <nct_id>NCT02672553</nct_id>
  </id_info>
  <brief_title>EDWARDS INTUITY Valve System CADENCE-MIS Study</brief_title>
  <acronym>CADENCE-MIS</acronym>
  <official_title>A Randomized Comparison of the EDWARDS INTUITY Valve Sys-tem anD commErcially Available Aortic Bioprostheses in Subjects uNdergoing surgiCal Aortic Valve Replacement Using Minimally Inva-Sive Techniques</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study purpose is to compare the EDWARDS INTUITY valve system in a minimal invasive
      surgical approach (MIS) with any commercially available aortic bioprosthesis in standard full
      ster-notomy surgical approach.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized study to compare the cross-clamp time (XCT) and cardiopulmonary bypass
      time (CPBT) of the EDWARDS INTUITY valve system in a minimally invasive surgical approach
      (MIS) with any commercially available aortic bioprosthesis in standard full sternotomy
      surgical approach, in patients with logistic EuroScore &lt; 20 undergoing elective isolated
      aortic valve replacement (AVR) surgery.

      Additionally, the aim is to gather sufficient data to quantify the effect size of short term
      patient benefit outcomes previously identified from literature and to explore additional
      healthcare resource utilization endpoints.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cross-clamp time</measure>
    <time_frame>At time of surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiopulmonary bypass time</measure>
    <time_frame>At time of surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>NYHA (assessed during follow up)</measure>
    <time_frame>Discharge, 30 days, 3 Months, 1 Year, 2 Years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-SD-questionnaire (6 questions)</measure>
    <time_frame>Discharge, 30 days, 3 Months, 1 Year, 2 Years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety Endpoints (Adverse Events observed after surgery)</measure>
    <time_frame>Discharge, 30 days, 3 Months, 1 Year, 2 Years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gradients (mmHg)</measure>
    <time_frame>Discharge, 30 days, 3 Months, 1 Year, 2 Years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VTI (cm)</measure>
    <time_frame>Discharge, 30 days, 3 Months, 1 Year, 2 Years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LVOT Diameter (cm)</measure>
    <time_frame>Discharge, 30 days, 3 Months, 1 Year, 2 Years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Annulus size (cm)</measure>
    <time_frame>Discharge, 30 days, 3 Months, 1 Year, 2 Years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Septal thickness (cm)</measure>
    <time_frame>Discharge, 30 days, 3 Months, 1 Year, 2 Years.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Aortic Valve Disease</condition>
  <condition>Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>EDWARDS INTUITY</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>EDWARDS INTUITY Valve System, Model 8300A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stented Aortic Bioprostheses</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Stented Aortic Bioprostheses</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EDWARDS INTUITY Valve System, Model 8300A</intervention_name>
    <description>To evaluate cardiac perfor-mance characteristics and ad-verse events rates associated with the EDWARDS INTUITY Valve in patients undergoing MIS-AVR.</description>
    <arm_group_label>EDWARDS INTUITY</arm_group_label>
    <other_name>aortic stenosis</other_name>
    <other_name>stenosis-based insufficiency</other_name>
    <other_name>aortic valve replacement</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stented Aortic Bioprostheses</intervention_name>
    <description>In comparison to control valves available on the market under-going FS-AVR</description>
    <arm_group_label>Stented Aortic Bioprostheses</arm_group_label>
    <other_name>aortic stenosis</other_name>
    <other_name>stenosis-based insufficiency</other_name>
    <other_name>aortic valve replacement</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion:

          1. ≥18 years of age

          2. aortic stenosis / mixed aortic stenosis and aortic insufficiency Log

          3. EuroSCORE &lt;20

          4. NYHA Class ≤II

        Exclusion (i.a.):

          1. pure aortic insufficiency

          2. previous cardiac surgery (involved FS or MIS approach)

          3. congenital true bicuspid / unicuspid aortic valve

          4. LVEF &lt;25%
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prof. Borger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Leipzig Heart Center</name>
      <address>
        <city>Leipzig</city>
        <state>Saxony</state>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 6, 2015</study_first_submitted>
  <study_first_submitted_qc>January 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2016</study_first_posted>
  <last_update_submitted>January 29, 2016</last_update_submitted>
  <last_update_submitted_qc>January 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aortic Valve Replacement</keyword>
  <keyword>Minimal Invasive Sternotomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

